← Leaderboards
Jennifer M. Yeh
Harvard School Of Public Health
$7,047,019
Attributed
$9,600,472
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,600,472 · 4
By mechanism
R01$4,794,093 · 2
U01$4,054,972 · 1
K07$751,407 · 1
Top collaborators
- Chin Hur5 shared
- Iris Lansdorp-Vogelaar3 shared
- Reinier Gs Meester1 shared
Most similar at Harvard School Of Public Health
Same institution · by research overlap
- Ruijia Chen$493,807
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsModels And SimulationHigh RiskRecommendationIncidenceFutureRisk FactorsPreventionMethodologyPrevalenceCancer ControlCessation Of LifeCohort StudiesRaceCaringSubgroupPublishingScreeningClinical ResearchInnovationAdultLesionMalignant Stomach NeoplasmGastric Cancer Prevention
Grant awards (19)
Comparative modeling of gastric cancer health drivers and prevention in the US and globally$899,170
U01 · FY2025 · CA
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care$705,394
R01 · FY2025 · CA · contact PI
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care$621,799
R01 · FY2024 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$615,728
U01 · FY2024 · CA
Comparative modeling of gastric cancer disparities and prevention in the US and globally$810,184
U01 · FY2023 · CA
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care$643,968
R01 · FY2023 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$810,695
U01 · FY2022 · CA
Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care$755,486
R01 · FY2022 · CA · contact PI
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future$400,065
R01 · FY2022 · CA · contact PI
Comparative modeling of gastric cancer disparities and prevention in the US and globally$919,195
U01 · FY2021 · CA
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future$400,065
R01 · FY2021 · CA · contact PI
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future$403,590
R01 · FY2020 · CA · contact PI
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future$403,427
R01 · FY2019 · CA · contact PI
Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future$460,299
R01 · FY2018 · CA · contact PI
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology$150,203
K07 · FY2014 · CA · contact PI
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology$151,002
K07 · FY2013 · CA · contact PI
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology$151,710
K07 · FY2012 · CA · contact PI
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology$150,520
K07 · FY2011 · CA · contact PI
Gastric Cancer Prevention: Evaluating U.S. Risk Factor Trends and New Technology$147,972
K07 · FY2010 · CA · contact PI